Regenerative Medicine Foundation
  • Leadership
  • What We Do
    • Our Event History
    • Policy
    • Advocacy
    • Education & Outreach
  • Events
    • Upcoming Events
    • Past Events
      • World Stem Cell Summit
      • Regenerative Medicine and Stem Cell Action Awards
      • Regenerative Medicine Essentials
      • The “Art of Science” Inspires Students
      • Exploring Public Policy: Regenerative Medicine and Cell Therapies
      • Congressional Briefings
      • World Stem Cell Summit – CHINA
  • Membership/Register
    • Membership
    • Amazon SMILE
  • News
    • News
    • Portraits of Hope
    • Video
    • Video Chats
  • Contact
  • Donate
Select Page
CRISPR and Single-cell Sequencing Pinpoint Causal Genetic Variants for Traits and Diseases

CRISPR and Single-cell Sequencing Pinpoint Causal Genetic Variants for Traits and Diseases

by admin | May 13, 2023 | News & Opinions

STING-seq provides roadmap to identify variants and genes, enabling deeper understanding of the noncoding genome and targets for therapies By NYU News A major challenge in human genetics is understanding which parts of the genome drive specific traits or contribute to...
Breakthrough research could bring stem cell therapy to the masses

Breakthrough research could bring stem cell therapy to the masses

by admin | May 12, 2023 | News & Opinions

by Justin Jackson – Phys.org Researchers at Sana Biotechnology, Inc., in California, have made a significant breakthrough in realizing the promise of stem cell therapy: stem cells that do not trigger an immune response from an immunologically incompatible donor....
Longeveron Announces New Long-Term Survival Data from ELPIS I Trial of Lomecel-B™ for Hypoplastic Left Heart Syndrome

Longeveron Announces New Long-Term Survival Data from ELPIS I Trial of Lomecel-B™ for Hypoplastic Left Heart Syndrome

by admin | May 10, 2023 | News & Opinions

By Longeveron MIAMI, May 09, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing regenerative medicines for unmet medical needs, today announced new...
From Private Astronaut Missions to In-Space Biomanufacturing: Axiom Space’s Bold Vision

From Private Astronaut Missions to In-Space Biomanufacturing: Axiom Space’s Bold Vision

by admin | May 9, 2023 | News & Opinions

by Innovation Quarter Some things are worth traveling for. We drive the extra hour to one-of-a-kind restaurants, we cross state lines for best-in-class specialists and we travel days to experience unrivaled natural wonders. One day, there will be products that we have...
Stay cool: the longevity tech that “shows insane promise

Stay cool: the longevity tech that “shows insane promise

by admin | May 6, 2023 | News & Opinions

Aubrey de Grey explains why the time is right to be extremely ambitious and audacious when it comes to longevity research. By Eleanor Garth – Longevity.Technology August will see the second annual Longevity Summit take place in Dublin. Packed with keynote...
Ax-2 Mission to Expand Microgravity Research to Combat Human Disease

Ax-2 Mission to Expand Microgravity Research to Combat Human Disease

by admin | May 5, 2023 | News & Opinions

By Axiom Space First time bioprinted solid tissue constructs to be sent to the International Space Station and induced pluripotent stem cells to be manufactured in space. Microgravity allows researchers to study the behavior of cells and tissues in a unique...
Page 109 of 206« First«108109110»Last »

Recent Posts

  • Interviews of 2025: The Big Issues
  • Case Study: Patient Remains Disease Free Five Years After Allogenic CAR T-Cell Therapy
  • To Bring Cell Culture into the Future, Consider Microenvironments
  • UC Irvine receives $12 million to test novel stem cell therapy for Huntington’s disease
  • Novel surgical approach for retinal gene therapy shows promise
Tweets about @WSCSummit